Iohexol Injection Market
Iohexol Injection Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Iohexol Injection Market Size and Growth
The global Iohexol Injection market is projected to witness significant growth due to the increasing prevalence of chronic diseases and the rising demand for advanced diagnostic imaging procedures. The market size is estimated to reach USD 500 million by 2025, with North America and Europe leading in market share.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ GE Healthcare
◍ Imax
◍ Grupo Juste
◍ Daiichi Sankyo
◍ Takeda
◍ Fuji Pharma
◍ Towaseiyaku
◍ Hikari Pharmaceutical
◍ YRPG
◍ BeiLu Pharma
The competitive landscape of Iohexol Injection market includes key players such as GE Healthcare, Imax, Grupo Juste, Daiichi Sankyo, Takeda, Fuji Pharma, Towaseiyaku, Hikari Pharmaceutical, YRPG, and BeiLu Pharma. These companies utilize Iohexol Injection for diagnostic imaging purposes and contribute to the growth of the market through innovation and strategic partnerships.
- GE Healthcare: $19.8 billion (2020)
- Daiichi Sankyo: $9.5 billion (2020)
- Takeda: $30.2 billion (2020) Request
Sample Report
Market Segmentation
By Application
◍ Hospitals
◍ Clinics
By Product
◍ 350mg I/ml
◍ 240mg I/ml
◍ 300mg I/ml
Request Sample Report
$ X Billion USD
Market Growth
Request Sample Report
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients